Aspirin has already been proven by numerous studies to be effective at preventing and lowering complications due to heart disease. In fact, researchers in 1974 found that Aspirin was so beneficial toward heart health that it was as much a staple to one’s long-term health as either diet or exercise. The recent oncological studies seem to back that assertion, showing a marked decrease in the cancer occurrences, short-term and long-term, as well as cases of mortality. Aspirin even lowered the likelihood of metastasizing cancers, decreasing the likelihood of cancer spreading to other parts of the body.
The studies concluded that, although the exact way in which aspirin has been able to mitigate the incidents and spread of cancer, its properties at least hint at how cancer may function within the body. For instance, aspirin serves as an anti-inflammatory, implying that cancer may function as a kind of inflammation within the body, or that inflammation may actually speed up the grown of cancer. Aspirin is also an anti-platelet agent, managing to thin the blood over time. This is beneficial given the tendency for cancers to increase the occurrence of blood clots in our vascular systems.
Aspirin still does have some drawbacks. It’s an acidic in chemical makeup and has been linked to various forms of ulcers and GI tract bleeding. However, with the payoffs of using it, particularly at low doses and daily, far outweigh its drawbacks.
As populations age and more people are looking for less expensive treatments and preventative medicines, aspirin seems to be a likely item for discussion. Afterall, Walter Breuning, who was 114 years old and the oldest living person when he passed away last April, had only take aspirin for medication his entire life. It may be that as our population ages, and healthcare costs continue to increase, one of our greatest hopes for longevity will have been sitting in our medicine cabinet the whole time.